Novavax’s COVID And Flu Vaccine Trial Paused By FDA Due To Serious Safety Concerns. Novavax Stocks Plunge On News.

Source: Reuters

The FDA had to step in and put a pause on Novavax’s new COVID and Flu Vaccine after test participants reported serious nerve damage during newer trials, and other concerns. Novavax stocks plunged 40% after news of the US Food and Drug Administration’s program halt became public.

Nerve damage and cardiac arrest are now on the higher end of reported symptoms during vaccination trials. Frontline Doctors predicted that when the chaos of COVID subsides and there is more focus and oversight into experimental vaccine trials, the truth about vaccine side effects and symptoms will become more recognizable. 5 years removed from the novel coronavirus first being reported in the US we are starting to understand more.